Oral weight management pill for adults with obesity
This study tests an oral medication (VK2735) that may help adults with obesity or overweight with weight-related health issues lose weight. Participants take the pill as part of the trial to see if it is safe and effective for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your body mass index (BMI) must be 30 or higher, or 27 or higher if you have a weight-related health condition like high blood pressure, high cholesterol, sleep apnea, or heart disease.
- Your weight must have been stable (not changed by 5% or more) in the last 3 months.
- You cannot have had weight-loss surgery (like gastric sleeve or lap band) or any planned surgery for obesity.
- You must not have diabetes (type 1 or type 2) and must not be taking diabetes medications within 90 days before screening.
- You must not have a personal or family history of medullary thyroid cancer or a condition called multiple endocrine neoplasia type 2, and no history of pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called VK2735 for weight management in adults with type 2 diabetes. The goal is to see if it helps with weight loss and blood sugar control.
This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.
This early-stage trial tests a new once-weekly medication (VK2735) that may help with weight loss. It's for healthy adults with obesity who do not have other significant health problems like diabetes.
This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.
This early-phase study tests an experimental medicine called VK3019 in adults who are overweight or have obesity but are otherwise healthy. The goal is to see if the drug is safe and how the body handles it, which may lead to future weight-management options.
This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.